Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.
Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia.
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition.
Myelination, oligodendrocytes, and serious mental illness.
Costs and quality of life in multiple sclerosis patients with spasticity.
Pediatric Inflammatory Diseases. Part II: Acute Post-Infectious Immune Disorders.
Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Hunting for autoantibodies in multiple sclerosis.
[Multiple sclerosis: a comprehensive treatment and rehabilitation].
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
Non pharmacological interventions for spasticity in multiple sclerosis.
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.
Substrate stiffness of endothelial cells directs LFA-1/ICAM-1 interaction: A physical trigger of immune-related diseases?
Predictors of recurrence following an initial episode of transverse myelitis.
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
Assessment of the Effect of Cigarette Smoking on Regional Brain Volumes and Lesion Load in Patients with Clinically Isolated Syndrome.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
Exercise training improves depressive symptoms in people with multiple sclerosis: Results of a meta-analysis.
Ocular nerve growth factor administration (oNGF) affects disease severity and inflammatory response in the brain of rats with experimental allergic encephalitis (EAE).
Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
Pages
« first
‹ previous
…
535
536
537
538
539
540
541
542
543
…
next ›
last »